<div id="readability-page-1">01:59 PM EST, 12/26/2025 (MT Newswires) -- Health care stocks declined Friday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 0.2%.The iShares Biotechnology ETF (IBB) decreased 0.8%.In corporate news, Johnson &amp; Johnson ( JNJ ) shares were down 0.4% after the company said Friday that a phase 2b trial assessing JNJ-95475939 in moderate to severe atopic dermatitis was terminated early after interim analysis showed that it did not meet the target efficacy.Eli Lilly ( LLY ) will pay a $40 million upfront payment and a $15 million equity investment to ABL Bio, the latter said Friday. The upfront payment of $40 million is for the license, research, and collaboration agreement for ABL's Grabody platform, ABL said, adding that the two parties are carrying out joint research and development on multiple therapeutic candidates. Eli Lilly ( LLY ) shares decreased 0.2%.Can-Fite BioPharma ( CANF ) shares jumped 20% after receiving a patent from the Brazilian Patent Office for its A3 adenosine receptor, or A3AR, drugs to treat sexual dysfunction. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

CANF

Health care stocks fell Friday afternoon, with NYSE Health Care Index and XLV ETF down 0.2%, and IBB ETF down 0.8%. Johnson & Johnson shares dropped 0.4% after a trial was terminated. Eli Lilly shares decreased 0.2% following a $40 million deal with ABL Bio. Can-Fite BioPharma shares surged 20% after a patent approval in Brazil.

Sector Update: Health Care Stocks Lower in Friday Afternoon Trading